Malaysian Government Reviewing Dangerous Drugs Act For Medical Cannabis
Cannabis Law Report
JANUARY 16, 2022
Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. This means Malaysia currently has no registered marijuana-based treatment.
Let's personalize your content